New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

2

T cell shortage linked to severe Covid-19 in elderly; antiseptic spray may limit virus spread

A lower supply of a certain type of immune cell in older people that is critical to fighting foreign invaders may help explain their vulnerability to severe Covid-19, scientists say. An antiseptic nasal spray containing povidone-iodine may help curb transmission of the new coronavirus, preliminary research suggests.

3

ESMO: Merck and AstraZeneca’s 5-Year Lynparza Data in Ovarian Cancer and More

AstraZeneca and Merck announced positive five-year follow-up data from the Phase III SOLO-1 trial which demonstrated a long-term progression-free survival benefit of Lynparza as a first-line maintenance treatment in patients with newly diagnosed, advanced BRCA-mutated ovarian cancer who were in complete or partial response to platinum-based chemotherapy.

4

Genentech Drug Benefits Patients with Covid-19-Associated Pneumonia, Study Shows

A rheumatoid arthritis drug developed by Genentech proved to be effective in benefitting patients who have Covid-19-associated pneumonia, according to new late-stage clinical trial data.

9

Silicon Valley startup Visby’s portable Covid-19 test gets FDA approval

Silicon Valley medical equipment startup Visby Medical received Emergency Use Authorization by the U.S. Food and Drug Administration for a portable PCR Covid-19 test kit, the first company to do so, according to the FDA.

10

U.S. plans for hundreds of millions of cheap, fast Covid-19 tests

U.S. manufacturers are sharply increasing production of cheap, fast – but less accurate – Covid-19 tests, aiming for 100 million per month by year-end 2020 that will enable schools and workplaces to significantly expand testing.